Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
作者信息
Han Changsu, Wang Sheng-Min, Bahk Won-Myong, Lee Soo-Jung, Patkar Ashwin A, Masand Prakash S, Mandelli Laura, Pae Chi-Un, Serretti Alessandro
机构信息
Department of Psychiatry, Korea University College of Medicine, Seoul, Korea.
Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641.
Abstract
摘要
相似文献
1
Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641.
2
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
J Clin Psychiatry. 2017 Jun;78(6):720-729. doi: 10.4088/JCP.15r10583.
3
4
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
Am J Geriatr Psychiatry. 2020 Sep;28(9):933-945. doi: 10.1016/j.jagp.2020.05.005. Epub 2020 May 19.
5
Randomized, controlled, participant- and rater-blind trial of pharmacogenomic test-guided treatment versus treatment as usual for major depressive disorder.
Depress Anxiety. 2020 Sep;37(9):834-841. doi: 10.1002/da.23029. Epub 2020 May 7.
6
A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):469-480. doi: 10.9758/cpn.2018.16.4.469.
7
Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial.
JAMA Psychiatry. 2016 Aug 1;73(8):789-95. doi: 10.1001/jamapsychiatry.2016.1031.
8
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
BMC Psychiatry. 2017 Jul 14;17(1):250. doi: 10.1186/s12888-017-1412-1.
9
Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.
J Psychiatr Res. 2015 Jul-Aug;66-67:84-94. doi: 10.1016/j.jpsychires.2015.04.020. Epub 2015 May 5.
10
A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder.
J Clin Psychopharmacol. 2006 Feb;26(1):56-60. doi: 10.1097/01.jcp.0000195042.62724.76.
引用本文的文献
1
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2021 Aug 12;21(13):1-214. eCollection 2021.
Zotero 插件